Listed

Quest Diagnostics Inc: Form 10-Q for the period ended Jun 30, 2022

Filed with the SEC on Jul 22, 2022 and accepted by EDGAR at Jul 22, 2022, 16:09 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2022-04-01 to 2022-06-30$2.45bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2022-01-01 to 2022-06-30$5.06bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2022-04-01 to 2022-06-30$1.61bnus-gaap:CostOfRevenue
Cost of revenue6 months2022-01-01 to 2022-06-30$3.26bnus-gaap:CostOfRevenue
Selling, general and administrative3 months2022-04-01 to 2022-06-30$422.0mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2022-01-01 to 2022-06-30$847.0mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2022-04-01 to 2022-06-30$388.0mus-gaap:OperatingIncomeLoss
Operating income6 months2022-01-01 to 2022-06-30$901.0mus-gaap:OperatingIncomeLoss
Interest expense3 months2022-04-01 to 2022-06-30$38.0mus-gaap:InterestExpense
Interest expense6 months2022-01-01 to 2022-06-30$75.0mus-gaap:InterestExpense
Income tax3 months2022-04-01 to 2022-06-30$77.0mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2022-01-01 to 2022-06-30$187.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2022-04-01 to 2022-06-30$234.0mus-gaap:NetIncomeLoss
Net income6 months2022-01-01 to 2022-06-30$589.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2022-04-01 to 2022-06-30$1.96us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2022-01-01 to 2022-06-30$4.88us-gaap:EarningsPerShareDiluted
Basic EPS3 months2022-04-01 to 2022-06-30$2.00us-gaap:EarningsPerShareBasic
Basic EPS6 months2022-01-01 to 2022-06-30$4.97us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2022-04-01 to 2022-06-30119,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2022-01-01 to 2022-06-30120,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2022-01-01 to 2022-06-30$882.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2022-01-01 to 2022-06-30$139.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid6 months2022-01-01 to 2022-06-30$152.0mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases6 months2022-01-01 to 2022-06-30$573.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2022-06-30$790.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-06-30$2.43bnus-gaap:AssetsCurrent
Total assetsAt period end2022-06-30$13.31bnus-gaap:Assets
Current liabilitiesAt period end2022-06-30$1.58bnus-gaap:LiabilitiesCurrent
Current portion of debtAt period end2022-06-30$2.0mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2022-06-30$6.41bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001022079-22-000123. Last ingested by Listed: Nov 13, 2026, 17:16 ET. Listed shows no prices and gives no investment advice.